Question 10492 — victim assistance

Summary

Mr. Benoît Biteau draws the attention of the Minister of Health, Families, Autonomy and People with Disabilities to the situation of victims of meningiomas caused by taking synthetic progestins such as Androcur (cyproterone acetate), Lutéran or Lutényl, prescribed in particular as part of hormonal treatments. From 2018, these medicines were the subject of supervision measures by the National Agency of medicines and health products (ANSM), after the identification of high risks of benign brain tumors (meningiomas). However, the first scientific alerts on these serious adverse effects date back to the early 2000s. Today, several hundred patients, supported by the AMAVEA association (Association meningiomas due to cyproterone acetate, assistance to victims and consideration of other molecules) and represented by a law firm, initiated legal proceedings against the pharmaceutical laboratories and against the State. The mobilized firm indicates that it is defending more than 750 cases, including 70 ongoing procedures, and has around forty definitive expert reports establishing a causal link between taking these treatments and the development of meningiomas causing serious after-effects. Facing the slowness and complexity of these legal procedures, the associations and lawyers representing the victims are requesting the creation of an amicable compensation system, based on the model of those established for Médiator (Benfluorex) and Dépakine (sodium valproate). Such a mechanism would allow more rapid recognition of the harm suffered, guarantee equal treatment between victims and avoid the trauma of long and costly procedures. He therefore asks the Government's intentions regarding the establishment of an amicable compensation system for victims of meningiomas linked to the taking of Androcur and other synthetic progestins and also wishes to know if the Government plans to integrate such a measure into the social security financing bill.

Machine translation from French. The official text remains authoritative.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

No documents linked.

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.